FutureStarr

Mia aesthetics atlanta

Mia aesthetics atlanta

Mia aesthetics atlanta

mia aesthetics has been helping Atlanta residents fight appearance-related issues since 2001. Our team is composed of professional aestheticians who offer beauty services including laser hair removal and face lifts.

Mia Aesthetics Credits Fast Expansion to Boom in Middle-Income Cosmetic Surgery Seekers

started 2021 with the addition of its seventh clinic in less than two years. The opening of the 16,000-square-foot facility in Atlanta, GA more than doubles the network of Mia clinics which have expanded from two states to five since 2019. Revenue doubled from 2019 to 2020, growing the network exponentially as a result of a spike in the number of savvy, 25 to 30-somethings earning between $30K to $50K choosing to make an investment in cosmetic surgery by U.S. board-certified plastic surgeons-a shift that also has the potential to forever disrupt the trend of traveling abroad for cosmetic surgery.

Beyondspring Stock Plunges After Fda Says Nda for Cin Treatment 'cannot Be Approved' in Current Form

Shares of BeyondSpring Inc. plunged 55.2% toward a record low in premarket trading Wednesday, after the biopharmaceutical company said that it has received a complete response letter (CRL) from the U.S. Food and Drug Administration, saying the biopharmaceutical company's new drug application (NDA) for its treatment for chemotherapy-induced neutropenia (CIN) "cannot be approved in its present form." The FDA said the results of the single registration trial (106 Phase 3) "was not sufficiently robu

2 Unstoppable Artificial-Intelligence Stocks to Buy for the New Year

Many companies use the term "artificial intelligence" (AI) to generate hype, but few of them successfully integrate AI to grow their business. Both Upstart Holdings (NASDAQ: UPST) and UiPath (NYSE: PATH) have used AI to drive their businesses. Upstart is using artificial intelligence to redefine how banks determine creditworthiness for loans.

3 Reasons Pfizer Stock Will Crush the Broader Market in 2022

Pfizer (NYSE: PFE) has been the second-best-performing big pharma stock for the whole of 2021. Pfizer's shares have soared this year due to its dominance in the COVID-19 vaccine market, as well as its late-stage trial success with the oral antiviral pill Paxlovid. Despite this sizable jump in 2021, Pfizer seems primed to crush the broader market yet again in 2022.

2 “strong Buy” Dividend Stocks With at Least 7% Dividend Yield

Welcome to the last month of 2021. If you’re confused on how to read current market conditions, you are probably not alone. The past 3 sessions have been marked by volatility with wild swings from one extreme to the other. The market appears to be lacking direction in the face of the Omicron variant’s rise and the Fed’s admission elevated inflation levels might not be transitory after all. It’s a moment made for defensive stocks, for the short-term hedges that protect an investment portfolio fro

 

 

Related Articles